We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Publishes More GDUFA III-Focused Guidances and Instructions
FDA Publishes More GDUFA III-Focused Guidances and Instructions
Since Congress reauthorized the FDA’s generic drug user fee program last Friday, the FDA has published multiple related guidances and other official instructions and directives each day.